How severe is CVE-2020-27256?

CVE-2020-27256 has a CVSS 3.x base score of 6.8, rated medium severity. It is exploitable over physical access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2020-27256 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (23rd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-27256?

CVE-2020-27256 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2020-27256?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2020-27256 published?

CVE-2020-27256 was published on 2021-01-19 and last updated on 2026-06-17.

CVE-2020-27256

CVE-2020-27256 is a medium-severity vulnerability in Sooil Anydana-a Firmware with a CVSS 3.x base score of 6.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-798.

Key facts

Severity: Medium (CVSS 3.x base score 6.8)
CVSS v2: 4.6
EPSS exploit prediction: 0% (23rd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-798
Affected product: Sooil Anydana-a Firmware
Published: 2021-01-19
Last modified: 2026-06-17

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.

Frequently asked questions

What is CVE-2020-27256?: In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.
How severe is CVE-2020-27256?: CVE-2020-27256 has a CVSS 3.x base score of 6.8, rated medium severity. It is exploitable over physical access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2020-27256 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (23rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-27256?: CVE-2020-27256 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-27256?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-27256 published?: CVE-2020-27256 was published on 2021-01-19 and last updated on 2026-06-17.

References

https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01

Affected products (3)

cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Sooil Anydana-a Firmware

CVE-2020-27264 — High (CVSS 8.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27268 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27266 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27269 — Medium (CVSS 5.7): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27276 — Medium (CVSS 5.7): SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its…
CVE-2020-27272 — Medium (CVSS 5.7): SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and…

All CVEs affecting Sooil Anydana-a Firmware →

Other CWE-798 (Use of Hard-coded Credentials) vulnerabilities

CVE-2026-13768 — Critical (CVSS 10.0): Gardyn devices expose a privileged iothubowner key. Access to this key will allow a malicious user to invoke an IoTHub…
CVE-2026-45631 — Critical (CVSS 10.0): Dokploy is a free, self-hostable Platform as a Service (PaaS). From 0.27.0 to before 0.29.3, a hardcoded…
CVE-2026-22769 — Critical (CVSS 10.0): Dell RecoverPoint for Virtual Machines, versions prior to 6.0.3.1 HF1, contain a hardcoded credential vulnerability.…
CVE-2025-42890 — Critical (CVSS 10.0): SQL Anywhere Monitor (Non-GUI) baked credentials into the code,exposing the resources or functionality to unintended…
CVE-2025-7503 — Critical (CVSS 10.0): An OEM IP camera manufactured by Shenzhen Liandian Communication Technology LTD exposes a Telnet service (port 23) with…
CVE-2025-20309 — Critical (CVSS 10.0): A vulnerability in Cisco Unified Communications Manager (Unified CM) and Cisco Unified Communications Manager Session…

Browse all CWE-798 (Use of Hard-coded Credentials) vulnerabilities →